
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>AGA Clinical Practice Update on Incorporating Functional Lumen Imaging Probe Into Esophageal Clinical Practice: Expert Review</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>AGA Clinical Practice Update on Incorporating Functional Lumen Imaging Probe Into Esophageal Clinical Practice: Expert Review</strong></summary>
            <div>
                <ul><li>Authors: Anh D. Nguyen, Dustin A. Carlson, Amit Patel, and C. Prakash Gyawali</li><li>Journal: Gastroenterology</li><li>Publication Date: 2025</li><li>Purpose: Summarize evidence &amp; offer expert advice on incorporating functional lumen imaging probe (FLIP) into clinical practice.</li><li>Focus: Utility in evaluating esophageal symptoms, motor dysfunction, gastroesophageal reflux disease (GERD), &amp; eosinophilic esophagitis (EoE).</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What is the negative predictive value of normal esophagogastric junction opening (NEO) on FLIP for disorders of esophagogastric junction outflow obstruction (EGJOO) on high-resolution manometry (HRM)?</li><li>2. What are the key metrics evaluated during a FLIP panometry study?</li><li>3. What endoscopic findings, when combined with reduced EGJ opening (REO) on FLIP, have a high positive predictive value for nonspastic achalasia?</li><li>4.  What is the CARS score, and what does it quantify?</li><li>5.  Should FLIP findings be used to diagnose GERD or determine the necessity for antireflux intervention?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Best Practice Advice Statements</strong></summary>
            <div>
                <ul><li>Statements developed based on literature review &amp; expert opinion.</li><li>Formal systematic reviews were not performed.</li><li>Statements lack formal ratings of evidence quality or strength of considerations.</li></ul>
                
        <details>
            <summary><strong>Advice 1: High-Quality Endoscopy First</strong></summary>
            <div>
                <ul><li>Clinicians should perform a high-quality upper endoscopy evaluating for esophageal pathology immediately prior to considering FLIP.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 2: Consider FLIP for Esophageal Obstruction Symptoms</strong></summary>
            <div>
                <ul><li>Consider FLIP if alternate investigations are inconclusive in patients w/ symptoms of esophageal obstruction (dysphagia, regurgitation, chest pain).</li><li>May consider FLIP as part of index endoscopy for symptomatic patients when expertise is readily available.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 3: Sedation Options</strong></summary>
            <div>
                <ul><li>Common sedation options (propofol, fentanyl, midazolam) can be used.</li><li>These medications have not been demonstrated to have a clinically significant impact on FLIP findings.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 4: NEO &amp; EGJOO</strong></summary>
            <div>
                <ul><li>Normal esophagogastric junction opening (NEO) on FLIP has a high negative predictive value for disorders of esophagogastric junction outflow obstruction (EGJOO) on high-resolution manometry (HRM).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 5: Achalasia Diagnosis w/ Endoscopy</strong></summary>
            <div>
                <ul><li>If upper endoscopy demonstrates findings strongly supportive of achalasia, clinicians may use FLIP findings to diagnose achalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 6: Further Testing for Abnormal EGJ Opening</strong></summary>
            <div>
                <ul><li>If upper endoscopy does not demonstrate findings supportive of achalasia, abnormal esophagogastric junction opening on FLIP should prompt further diagnostic testing.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 7: FLIP for Dysphagia in Treated EoE</strong></summary>
            <div>
                <ul><li>Clinicians may consider performing FLIP if the mechanism of persisting dysphagia in treated eosinophilic esophagitis (EoE) is not apparent on high-quality upper endoscopy or histopathology.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 8: Avoid FLIP for GERD Diagnosis</strong></summary>
            <div>
                <ul><li>Clinicians should not use FLIP findings to diagnose gastroesophageal reflux disease (GERD) or to determine the necessity for antireflux intervention.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 9: Intraprocedural FLIP During Myotomy</strong></summary>
            <div>
                <ul><li>When available, clinicians should consider performing FLIP intraprocedurally during myotomy (per-oral endoscopic myotomy (POEM) or laparoscopic Heller myotomy (LHM)) to guide adequacy of LES disruption.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 10: FLIP for Persistent Symptoms Post-Achalasia Treatment</strong></summary>
            <div>
                <ul><li>Clinicians may consider performing FLIP in the evaluation of persisting symptoms of esophageal obstruction (dysphagia, regurgitation, chest pain) after treatment of achalasia spectrum disorders.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Advice 11: FLIP for Symptoms Post-Foregut Intervention</strong></summary>
            <div>
                <ul><li>Clinicians may consider performing FLIP in the evaluation of symptoms of esophageal obstruction after invasive foregut intervention (antireflux or bariatric intervention).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Protocol and Interpretation</strong></summary>
            <div>
                <ul><li>FLIP uses impedance planimetry to evaluate cross-sectional area (diameter), distensibility of EGJ &amp;/or esophageal body, &amp; esophageal body contractile response to volumetric distention.</li><li>Equipment: FLIP catheter w/ impedance planimetry electrodes &amp; pressure transducer inside polyurethane bag, &amp; digital data acquisition &amp; display system.</li><li>Catheter types: 8-cm (EGJ metrics) &amp; 16-cm (EGJ metrics &amp; esophageal body contractile response).</li></ul>
                
        <details>
            <summary><strong>Procedure</strong></summary>
            <div>
                <ul><li>Performed in sedated patient after high-quality upper endoscopy in left lateral position.</li><li>Catheter calibrated, referenced to atmospheric pressure, &amp; positioned transorally.</li><li>Positioning: 1–3 impedance sensor pairs distal to EGJ (16-cm catheter) or EGJ @ balloon center (8-cm catheter). Confirmed by identifying EGJ “waist” on real-time display @ 30–40 mL or 20-mL fill volumes, respectively.</li></ul>
                
        <details>
            <summary><strong>Positioning Considerations</strong></summary>
            <div>
                <ul><li>If resistance encountered during positioning, catheter withdrawn &amp; repositioned to avoid damaging distal pressure transducer.</li><li>Endoscopic visualization may be helpful in patients w/ abnormal anatomy (esophageal diverticulum, hiatus hernia) or prior foregut surgery (Roux-en-Y gastric bypass).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry Study</strong></summary>
            <div>
                <ul><li>Sequential saline infusion into FLIP bag to 50 mL, 60 mL, &amp; 70 mL.</li><li>Each fill volume held for ≥30 seconds while maintaining appropriate FLIP catheter position.</li><li>Key metrics: EGJ distensibility index (DI; ratio of cross-sectional area to bag pressure) &amp; associated pressure measured @ 60-mL fill volume, maximum EGJ diameter @ 70-mL fill volume, &amp; esophageal body contractile pattern based on aggregate of 50-mL, 60-mL, &amp; 70-mL fill volumes.</li></ul>
                
        <details>
            <summary><strong>8-cm Catheter</strong></summary>
            <div>
                <ul><li>Similar stepwise FLIP filling to 30 mL, 40 mL, &amp; 50 mL.</li><li>Evaluating EGJ diameter, pressure, &amp; EGJ-DI @ each fill volume.</li><li>Recording metrics from 40-mL fill volume.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>EGJ Opening Description</strong></summary>
            <div>
                <ul><li>Described using 2 parameters: EGJ-DI &amp; maximum EGJ diameter.</li><li>Categories: Normal EGJ opening (NEO), reduced EGJ opening (REO), or inconclusive EGJ opening (IEO).</li><li>Esophageal body contractile response patterns: normal (multiple distinct anterograde contractions &amp;/or repetitive anterograde contractions) or abnormal (absent, diminished, disordered, or spastic contractile response patterns).</li></ul>
                
        <details>
            <summary><strong>Pressure Measurements</strong></summary>
            <div>
                <ul><li>FLIP pressure measurements discriminate diminished (≤40 mm Hg) from disordered (&gt;40 mm Hg) contractility when distinct antegrade contractions or spastic contractile response are not seen.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP in Evaluation of Esophageal Symptoms</strong></summary>
            <div>
                <ul><li>FLIP findings should be interpreted as part of the global clinical impression, in the context of presenting symptoms, endoscopy findings, &amp; relevant complementary test results.</li></ul>
                
        <details>
            <summary><strong>High-Quality Upper Endoscopy</strong></summary>
            <div>
                <ul><li>Carefully evaluates for structural &amp; mucosal abnormalities.</li><li>Higher yield for erosive reflux changes or EoE if PPIs withheld for 2–4 weeks.</li><li>FLIP contraindicated in patients w/ actively bleeding varices.</li></ul>
                
        <details>
            <summary><strong>Endoscopic Findings</strong></summary>
            <div>
                <ul><li>Esophageal strictures, rings, mass lesions, diverticula, mucosal changes of EoE, erosive esophagitis, Barrett’s esophagus, &amp; spastic changes should be noted.</li><li>Biopsies obtained when appropriate.</li><li>Careful retroflexion after gastric air insufflation evaluates for hiatus hernia (Hill or American Foregut Society grade), abnormalities in gastric cardia, &amp; postoperative foregut anatomy (integrity &amp; location of ARS).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP for Inconclusive Investigations</strong></summary>
            <div>
                <ul><li>Neither HRM, TBE, nor FLIP represents a “gold standard” for diagnosis of esophageal motility disorders in isolation.</li><li>Inconclusive findings of uncertain clinical relevance may be encountered (e.g., EGJOO on HRM is considered inconclusive).</li></ul>
                
        <details>
            <summary><strong>Discordance Among Tests</strong></summary>
            <div>
                <ul><li>Discordance between esophageal test findings is not unusual.</li><li>Concordant findings on &gt;1 testing modality increase confidence in diagnosis of actionable obstructive motility disorders prior to pursuing irreversible LES disruption.</li><li>Conservative treatments should be used if a confident achalasia spectrum diagnosis cannot be made.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Cost-Effectiveness</strong></summary>
            <div>
                <ul><li>FLIP can be cost-effective during index endoscopy when completely normal or facilitates early achalasia diagnosis.</li><li>Adds an average of only 5 additional minutes to the procedure time.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Alternative to HRM</strong></summary>
            <div>
                <ul><li>FLIP remains an option to assess esophageal motility when HRM catheter fails to traverse the LES, discomfort/gagging precludes adequate HRM study, or alternate testing demonstrates dilated/tortuous esophagus.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Sedation Impact on FLIP</strong></summary>
            <div>
                <ul><li>Chronic opiate use associated w/ opiate-induced esophageal dysmotility on HRM.</li><li>FLIP &amp; HRM diagnoses not significantly different in study comparing FLIP w/ conscious sedation (midazolam &amp; fentanyl) &amp; monitored anesthesia care (propofol, w/ or w/o fentanyl).</li></ul>
                
        <details>
            <summary><strong>Inhalation Anesthetics</strong></summary>
            <div>
                <ul><li>Sevoﬂurane can result in higher EGJ diameter &amp; EGJ-DI readings compared w/ propofol, &amp; can impair secondary peristalsis.</li><li>Clinicians should avoid inhalation anesthetics when assessing esophageal motility w/ FLIP panometry until more data are available.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP in Evaluation of Esophageal Motility Disorders</strong></summary>
            <div>
                <ul><li>NEO on FLIP has a high negative predictive value for disorders of EGJOO on HRM.</li></ul>
                
        <details>
            <summary><strong>NEO &amp; EGJOO Studies</strong></summary>
            <div>
                <ul><li>Study of 687 symptomatic patients w/o mechanical obstruction on endoscopy found NEO in &lt;1% of 243 patients w/ HRM diagnoses of achalasia or conclusive EGJOO confirmed w/ TBE.</li><li>Study of 184 patients showed none of 23 patients w/ HRM-defined achalasia had NEO on FLIP.</li></ul>
                
        <details>
            <summary><strong>Negative Predictive Value</strong></summary>
            <div>
                <ul><li>NEO on FLIP offers high negative predictive value (NPV) for actionable EGJ obstruction as a mechanism for symptoms.</li><li>Further tests will have limited value.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>EGJ-DI Thresholds</strong></summary>
            <div>
                <ul><li>FLIP diagnostic performance to rule out achalasia or conclusive EGJOO varied according to the EGJ-DI threshold applied.</li><li>NPVs: 90% for EGJ-DI &gt;2.0 mm²/mm Hg, 96% for EGJ-DI &gt;2.8 mm²/mm Hg, &amp; 97% for EGJ-DI &gt;3.0 mm²/mm Hg.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>NEO &amp; Contractile Response</strong></summary>
            <div>
                <ul><li>Combining NEO w/ normal esophageal body contractile response pattern provides additional evidence against achalasia.</li><li>Study of 706 symptomatic patients: none of 108 patients w/ normal contractile response (repetitive antegrade contractions) had achalasia on HRM.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Achalasia Diagnosis w/ Endoscopy &amp; FLIP</strong></summary>
            <div>
                <ul><li>FLIP findings of REO &amp; abnormal contractile response patterns are strongly associated w/ achalasia.</li><li>Prior work: 92% of patients (n = 185 of 202) w/ REO &amp; absent or impaired/disordered esophageal body contractile response had achalasia or conclusive (TBE-confirmed) EGJOO on HRM.</li></ul>
                
        <details>
            <summary><strong>Advantage of FLIP</strong></summary>
            <div>
                <ul><li>Key advantage of FLIP over HRM is accompanying high-quality endoscopy, which provides valuable pretest probability to complement FLIP findings, including distinction of idiopathic achalasia from pseudoachalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Endoscopic Features of Achalasia</strong></summary>
            <div>
                <ul><li>Endoscopic features of achalasia: retained food/fluid (esophageal contents), dilated lumen (anatomy), resistance traversing the EGJ, &amp; stasis changes of esophageal mucosa, quantified as CARS score.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>CARS Score</strong></summary>
            <div>
                <ul><li>CARS score ≥4 had specificity of 99% &amp; sensitivity of 68%–72% to identify achalasia.</li><li>CARS score of 0–1 combined w/ NEO on FLIP had NPV of 100% for achalasia spectrum disorders.</li><li>CARS score ≥4 w/ REO on FLIP had positive predictive value of 97% for nonspastic achalasia.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Further Testing for Abnormal EGJ Opening</strong></summary>
            <div>
                <ul><li>REO can be seen in 5%–11% of symptomatic patients w/o HRM disorders of EGJOO.</li><li>Clinical significance of REO on FLIP when HRM EGJ outflow pressures are normal is incompletely understood.</li><li>Borderline/inconclusive EGJ opening reported in 25%–28% of patients w/ normal EGJ outflow pressure on HRM &amp; could indicate obstruction.</li></ul>
                
        <details>
            <summary><strong>FLIP-HRM Discordance</strong></summary>
            <div>
                <ul><li>Given potential for FLIP-HRM discordance, if abnormal EGJ opening on FLIP is not supported by endoscopic evidence of achalasia, additional testing should be pursued before achalasia is diagnosed.</li><li>Careful re-inspection during the same endoscopic encounter can identify strictures or rings contributing to FLIP findings.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP in Evaluation of Eosinophilic Esophagitis</strong></summary>
            <div>
                <ul><li>FLIP can assess biomechanical properties of the esophageal wall in EoE.</li></ul>
                
        <details>
            <summary><strong>Distensibility Plateau</strong></summary>
            <div>
                <ul><li>Static esophageal diameter despite increasing distention volume &amp; pressure (distensibility plateau) was lower in patients w/ prior food impaction compared w/ those w/ dysphagia alone.</li><li>Low DI, particularly low distensibility plateau, correlates w/ greater symptom duration &amp; diagnostic delay in EoE.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Esophageal Body Contractile Response</strong></summary>
            <div>
                <ul><li>Abnormal esophageal body contractile response is associated w/ more severe fibrostenosis, indicating that EoE disease severity can impact esophageal motor function.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Composite Assessment</strong></summary>
            <div>
                <ul><li>Composite assessment of esophageal body compliance, contractility, EGJ-DI, &amp; maximal diameter correlates w/ higher esophageal eosinophil counts &amp; endoscopic reference scores when abnormal in a cohort of 215 patients w/ EoE.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Achalasia-like Pattern</strong></summary>
            <div>
                <ul><li>Rarely, an achalasia-like pattern can be seen in EoE that may be related to fibrostenotic change manifesting as pseudoachalasia.</li><li>Irreversible LES-disruptive treatments should be applied cautiously &amp; only if supported by additional complementary tests.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>PPI Nonresponse</strong></summary>
            <div>
                <ul><li>Abnormal composite FLIP assessment scores were associated w/ histologic PPI nonresponse in a cohort of 46 patients studied before treatment.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP in Evaluation of Gastroesophageal Reflux Disease</strong></summary>
            <div>
                <ul><li>FLIP studies evaluating EGJ barrier function in GERD have not demonstrated a discriminative threshold for EGJ-DI in segregating symptomatic GERD from controls.</li></ul>
                
        <details>
            <summary><strong>EGJ-DI &amp; AET</strong></summary>
            <div>
                <ul><li>No correlation between EGJ-DI values &amp; acid exposure times (AETs) in 2 retrospective evaluations of 164 patients &amp; 69 patients who underwent both FLIP &amp; ambulatory reflux monitoring.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>PPI Nonresponders</strong></summary>
            <div>
                <ul><li>Among 18 PPI nonresponders w/ normal AET on all 4 days of a 96-hour wireless pH monitoring study, the likelihood of DI &lt;2.8 mm²/mm Hg was higher (83.3%) compared w/ patients w/ abnormal reflux burden (23.5%).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Esophageal Body Contractile Response</strong></summary>
            <div>
                <ul><li>Impaired esophageal body contractile response has been associated w/ abnormal AET in a study w/ 25 patients, supporting abnormal esophageal clearance contributing to abnormal AET.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Hiatus Hernia</strong></summary>
            <div>
                <ul><li>FLIP can identify a hiatus hernia, w/ 84% correlation w/ HRM-identified hiatus hernia in a study of 100 consecutive patients.</li><li>FLIP can elicit or enlarge a hiatus hernia in up to 25%; patients w/ these features trended toward having barium retention on TBE.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Utility of FLIP in Foregut Interventions</strong></summary>
            <div>
                <ul><li>FLIP has demonstrable value when performed during intervention for achalasia spectrum disorders.</li></ul>
                
        <details>
            <summary><strong>Intraprocedural FLIP</strong></summary>
            <div>
                <ul><li>By evaluating the LES while POEM or LHM are in progress, intraprocedural FLIP can direct myotomy length &amp; confirm the adequacy of LES disruption in real time.</li><li>EGJ-DI reliably improves after myotomy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Intraoperative EGJ-DI</strong></summary>
            <div>
                <ul><li>Intraoperative EGJ-DI &lt;2–3 mm²/mm Hg may predict persisting symptoms, &amp; may prompt additional myotomy.</li><li>High intraoperative EGJ-DI may associate w/ postoperative reflux &amp;/or erosive esophagitis after LHM or POEM.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP in Symptom Evaluation After Foregut Interventions</strong></summary>
            <div>
                <ul><li>FLIP can be used to evaluate patients w/ persisting esophageal obstructive symptoms after achalasia management.</li></ul>
                
        <details>
            <summary><strong>Post-LES Disruption</strong></summary>
            <div>
                <ul><li>After LES disruption, an EGJ-DI &lt;2–3 mm²/mm Hg in symptomatic patients is associated w/ higher Eckardt scores &amp; suboptimal esophageal emptying, suggesting ineffective or incomplete LES disruption.</li><li>NEO on FLIP should prompt consideration of alternate explanations for symptoms, including abnormal esophageal body anatomy &amp; GERD.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Post-ARS</strong></summary>
            <div>
                <ul><li>Intraoperative FLIP during ARS &amp; endoscopic reflux procedures is feasible, &amp; EGJ-DI has been used to tailor fundoplication in attempts to prevent postoperative dysphagia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>EGJ-DI After ARS</strong></summary>
            <div>
                <ul><li>EGJ-DI &lt;2 mm²/mm Hg after ARS was associated w/ dysphagia symptoms.</li><li>Tightness of hiatal closure appears to impact DI more than the actual fundoplication.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Magnetic Sphincter Augmentation</strong></summary>
            <div>
                <ul><li>Postoperative diameter &amp; EGJ-DI were lower after magnetic sphincter augmentation compared w/ ARS, but symptomatic outcomes were similar.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Post-Bariatric Surgery</strong></summary>
            <div>
                <ul><li>FLIP performed after Roux-en-Y gastric bypass or sleeve gastrectomy has demonstrated higher secondary dysmotility (most commonly absent contractility) compared w/ obese patients w/ native anatomy.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Abnormal Secondary Peristalsis</strong></summary>
            <div>
                <ul><li>Among patients undergoing FLIP for symptomatic esophageal evaluation after ARS, abnormal secondary peristalsis was encountered in 84%, potentially worsening w/ longer duration post-ARS &amp;/or EGJ outflow resistance.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Conclusions</strong></summary>
            <div>
                <ul><li>FLIP is safe, adds minimal time to the standard endoscopic procedure, does not appear to be impacted by standard sedation used during endoscopy, &amp; may provide immediate management options after real-time interpretation.</li><li>Operator education is paramount.</li><li>The recently published FLIP Panometry classification scheme standardizes protocols, terminology, &amp; utilization of metrics in the diagnosis of motor &amp; structural esophageal disorders.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Future Directions</strong></summary>
            <div>
                <ul><li>Inconclusive &amp; discordant findings are also encountered w/ FLIP, &amp; future research is anticipated to further refine next steps in such scenarios.</li><li>The esophageal smooth muscle response to distention warrants further clarification.</li><li>Artificial intelligence is expected to further enhance FLIP interpretation.</li><li>The role of FLIP in adjudicating the diagnosis of functional dysphagia warrants additional research.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
